Yes. For conditions where positive specimens are difficult to acquire in sufficient numbers, we use targeted recruitment and pre-screening strategies aligned to your inclusion and exclusion criteria. Our multi-region site network across the US and international locations supports the accrual rates and demographic diversity that single-geography providers cannot reach.
Does DCN Dx handle low-prevalence or rare disease-state specimens?
May 31 2026
- FAQ





